{{Rsnum
|rsid=500760
|Gene=PGR
|Chromosome=11
|position=101039260
|Orientation=minus
|ReferenceAllele=A
|GMAF=0.2911
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PGR
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 56.6 | 35.4 | 8.0
| HCB | 63.5 | 32.1 | 4.4
| JPT | 61.9 | 28.3 | 9.7
| YRI | 36.7 | 52.4 | 10.9
| ASW | 43.9 | 45.6 | 10.5
| CHB | 63.5 | 32.1 | 4.4
| CHD | 55.0 | 40.4 | 4.6
| GIH | 77.2 | 21.8 | 1.0
| LWK | 29.1 | 50.9 | 20.0
| MEX | 44.8 | 41.4 | 13.8
| MKK | 34.0 | 51.9 | 14.1
| TSI | 57.8 | 36.3 | 5.9
| HapMapRevision=28
}}
{{PMID Auto
|PMID=19267271
|Title=Progesterone receptor polymorphism is associated with pelvic organ prolapse risk. Warning: auto generated link, to a study involving very small sample sizes and no statistical summary in abstract.
}}

This SNP in the progesterone receptor [[PGR]] gene is not likely to increase the risk of [[breast cancer]]. {{PMID|16614108}}

{{PMID Auto
|PMID=21600550
|Title=Progesterone receptor polymorphisms and clinical response to 17-alpha-hydroxyprogesterone caproate
|OA=1
}}

{{PMID Auto
|PMID=16126772
|Title=Association between polymorphisms in the progesterone receptor gene and endometriosis.
}}

{{PMID Auto
|PMID=17592773
|Title=Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies.
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}